Frontline transplantation of autologous CD34+ selected blood cells for advanced mantle cell lymphoma: no evidence of long-term cure: a single centre experience
- 1 November 2000
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 26 (10), 1138-1139
- https://doi.org/10.1038/sj.bmt.1702673
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patientsThe Hematology Journal, 2000
- Peripheral blood stem cell contamination in mantle cell non-Hodgkin lymphoma: the case for purging?Bone Marrow Transplantation, 1999
- Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma.Journal of Clinical Oncology, 1998
- Mantle cell lymphoma: a retrospective study of 121 casesLeukemia, 1998
- High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.Journal of Clinical Oncology, 1998
- A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's LymphomaBlood, 1997
- A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group [see comments]Blood, 1994